Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by D H Pamphilon
Early Lymphocyte Recovery Is an Important Determinant of Outcome Following Allogeneic Transplantation With CD34+ Selected Graft and Limited T-Cell Addback
Bone Marrow Transplantation
Transplantation
Hematology
Related publications
Predictors of Recovery Following Allogeneic CD34+-selected Cell Infusion Without Conditioning to Correct Poor Graft Function
Haematologica
Hematology
Donor T-Lymphocyte Infusion for Unrelated Allogeneic Bone Marrow Transplantation With CD3+ T-Cell-Depleted Graft
Bone Marrow Transplantation
Transplantation
Hematology
Individually Adjusted Prophylactic Donor Lymphocyte Infusions After CD34-selected Allogeneic Peripheral Blood Stem Cell Transplantation
Bone Marrow Transplantation
Transplantation
Hematology
Early Fluid Overload Is a Serious Toxicity Associated With an Increased Risk of Non-Relapse Mortality After Ex-Vivo CD34-Selected Allogeneic Hematopoietic Cell Transplantation
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
CD34+-Selected Stem Cell Boost Without Further Conditioning for Poor Graft Function After Allogeneic Stem Cell Transplantation in Patients With Hematological Malignancies
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
CD34-selected Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Relapsed, High-Risk Multiple Myeloma
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
Effect of Total Nucleated and CD34+ Cell Dose on Outcome After Allogeneic Hematopoietic Stem Cell Transplantation
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Early T-Cell Chimerism Is Valuable in Predicting Early Mortality From Steroid-Resistant Acute Graft Versus Host Disease After Myeloablative Allogeneic Haematopoietic Cell Transplantation
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
CD34+ Selected Ex-Vivo T-Cell Depleted (TCD) Grafts for Allogeneic Hematopoietic Cell Transplantation (Allo-Hsct) Is Associated With Low Incidence of Acute and Chronic Graft-Versus-Host Disease (GVHD) and High Chronic-GVHD/Relapse-Free Survival
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
